The interplay between Epstein–Barr virus and B lymphocytes: implications for infection, immunity, and disease

PI3Kδ Inhibition Augments the Efficacy of Rapamycin in Suppressing Proliferation of Epstein−Barr Virus (EBV)+ B Cell Lymphomas

(2013) S. Furukawa et al.   AMERICAN JOURNAL OF TRANSPLANTATION

MHC II tetramers visualize human CD4+T cell responses to Epstein–Barr virus infection and demonstrate atypical kinetics of the nuclear antigen EBNA1 response

(2013) Heather M. Long et al.   JOURNAL OF EXPERIMENTAL MEDICINE

A Distinct Subpopulation of Human NK Cells Restricts B Cell Transformation by EBV

(2013) A. Lunemann et al.   JOURNAL OF IMMUNOLOGY

Mg2+ Regulates Cytotoxic Functions of NK and CD8 T Cells in Chronic EBV Infection Through NKG2D

(2013) B. Chaigne-Delalande et al.   SCIENCE

Human Natural Killer Cells Prevent Infectious Mononucleosis Features by Targeting Lytic Epstein-Barr Virus Infection

(2013) Obinna Chijioke et al.   Cell Reports

Virus-Encoded microRNAs: An Overview and a Look to the Future

(2013) Rodney P. Kincaid et al.   PLoS Pathogens

Increased CD8+ T Cell Response to Epstein-Barr Virus Lytic Antigens in the Active Phase of Multiple Sclerosis

(2013) Daniela F. Angelini et al.   PLoS Pathogens

B-cell activation induced microRNA-21 is elevated in circulating B cells preceding the diagnosis of AIDS-related non-Hodgkin lymphomas

(2012) Dharma R. Thapa et al.   AIDS

Immune Regulatory Function of B Cells

(2012) Claudia Mauri et al.   Annual Review of Immunology

Bilateral adrenal EBV-associated smooth muscle tumors in a child with a natural killer cell deficiency

(2012) R. K. Shaw et al.   BLOOD

Persistence of Epstein-Barr Virus in Self-Reactive Memory B Cells

(2012) S. I. Tracy et al.   JOURNAL OF VIROLOGY

Src Kinase and Syk Activation Initiate PI3K Signaling by a Chimeric Latent Membrane Protein 1 in Epstein-Barr Virus (EBV)+ B Cell Lymphomas

(2012) Olivia Hatton et al.   PLoS One

Epstein-Barr Virus Infection of Naïve B Cells In Vitro Frequently Selects Clones with Mutated Immunoglobulin Genotypes: Implications for Virus Biology

(2012) Emily Heath et al.   PLoS Pathogens

The EBV Immunoevasins vIL-10 and BNLF2a Protect Newly Infected B Cells from Immune Recognition and Elimination

(2012) Simon Jochum et al.   PLoS Pathogens

The Viral and Cellular MicroRNA Targetome in Lymphoblastoid Cell Lines

(2012) Rebecca L. Skalsky et al.   PLoS Pathogens

Syk Activation of Phosphatidylinositol 3-Kinase/Akt Prevents HtrA2-dependent Loss of X-linked Inhibitor of Apoptosis Protein (XIAP) to Promote Survival of Epstein-Barr Virus+ (EBV+) B Cell Lymphomas

(2011) Olivia Hatton et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

EBV-Specific CD8+ T Cells from Asymptomatic Pediatric Thoracic Transplant Patients Carrying Chronic High EBV Loads Display Contrasting Features: Activated Phenotype and Exhausted Function

(2011) C. Macedo et al.   JOURNAL OF IMMUNOLOGY

Epstein-Barr Virus Infection of Polarized Epithelial Cells via the Basolateral Surface by Memory B Cell-Mediated Transfer Infection

(2011) Claire Shannon-Lowe et al.   PLoS Pathogens

MicroRNAs as Immune Regulators: Implications for Transplantation

(2010) A. Harris et al.   AMERICAN JOURNAL OF TRANSPLANTATION

OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma

(2010) Pedro P. Medina et al.   NATURE

The Epstein-Barr virus Bcl-2 homolog, BHRF1, blocks apoptosis by binding to a limited amount of Bim

(2009) A. L. Desbien et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: A need for reappraisal

(2009) Cindy M. Chang et al.   VIRUS RESEARCH

The Epstein-Barr Virus G-Protein-Coupled Receptor Contributes to Immune Evasion by Targeting MHC Class I Molecules for Degradation

(2009) Jianmin Zuo et al.   PLoS Pathogens

Tumor-derived Variants of Epstein-Barr Virus Latent Membrane Protein 1 Induce Sustained Erk Activation and c-Fos

(2008) Maria Vaysberg et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Epstein-Barr virus evasion of CD8+ and CD4+ T cell immunity via concerted actions of multiple gene products

(2008) Maaike E. Ressing et al.   SEMINARS IN CANCER BIOLOGY